Phillip Blanchette
Associate Professor
P: 519-685-8640
E-mail: phillip.blanchette@lhsc.on.ca
Administrative Assistant
Sovantena Kong
E-mail: sovantena.kong@lhsc.on.ca
Appointments
- Cross-Appointed Associate Professor in the Department of Oncology
Research Cluster Membership
Research Interests
- Health services research investigating cancer clinical outcomes
- Health equity
- Drug safety
Short Bio
Dr. Blanchette received his MD from the University of Ottawa in 2009 and post-graduate training in Internal Medicine (2009-2012) and Medical Oncology (2012-2014) at The University of Toronto. Thereafter, Dr. Blanchette completed a specialized breast cancer fellowship at the Sunnybrook Odette Cancer Centre (2014-2016). He also has completed a Masters degree in Clinical Epidemiology and Health Care Research at The Institute of Health Policy, Management and Evaluation at The University of Toronto in 2016.
Dr. Blanchette’s clinical and research expertise is in breast and lung cancer. He is a medical oncologist at The Verspeeten Family Cancer Centre, London Health Sciences Centre, since 2016 and is currently an Associate Professor of Oncology at The University of Western Ontario. His research specializes in health services research focusing on cancer clinical outcomes, health equity and drug safety. Dr. Blanchette is an adjunct scientist at the Institute of Clinical Evaluative Sciences (ICES). Dr. Blanchette is a member of the Canadian Drug Agency (CDA-AMC) pan-Canadian Oncology Drug Review Expert Review Committee (pERC) and a member of the Ontario Health-Cancer Care Ontario’s (OH-CCO) breast cancer drug advisory committee.
